Ramya Thota

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 312 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Barriers and Facilitators to Telemedicine: Can You Hear Me Now?

Ana María López, Kenneth Lam, Ramya Thota · American Society of Clinical Oncology Educational Book · 2021 · 151 citations · Full text

Medicine, Health Services Administration, Health Systems +16

Treatment of metastatic pancreatic adenocarcinoma: a review.

Ramya Thota, James M. Pauff, Jordan Berlin · PubMed · 2014 · 128 citations

Medicine, Oncology, Pharmacology +17

Patterns of chemotherapy‐associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study

Eva Culakova, Ramya Thota, Marek S. Poniewierski et al. · Cancer Medicine · 2014 · 120 citations · Full text

Medicine, Oncology, Cancer Drug Toxicity Management +15

American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care

Nathan A. Pennell, Melissa S. Dillmon, Laura A. Levit et al. · Journal of Clinical Oncology · 2020 · 85 citations · Full text

Medicine, Clinical Sciences, Oncology +17